EMA: Waiving MD study [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2020-09-09 17:43 (177 d 12:30 ago) – Posting: # 21913
Views: 1,980

Hi Helmut,

» at the end an [image] script to play with.
» For any elimination half life of > 7 hours and an intended dosing interval of 24 hours it will be impossible to get the MD study waived. Red are formulations with flip-flop PK (kakel).

Could you please kindly add more explanation.


Complete thread:

 Admin contact
21,370 posts in 4,463 threads, 1,495 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Saturday 05:13 CET (Europe/Vienna)

If debugging is the process of removing bugs,
then programming must be the process of putting them in.    Edsger W. Dijkstra

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz